CoChat
Cited by 30

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease

Palacios, Natalia, Hannoun, Anas, Flahive, Julie, Ward, Doyle, Goostrey, Kelsey, Deb, Anindita, Smith, Kara M. · 2021 · Frontiers in Neurology

Abstract

Background: The impact of Levodopa on the gut microbiota of Parkinson's disease (PD) patients has not been sufficiently addressed. Methods: We conducted a longitudinal study to examine the impact of Levodopa initiation on the gut microbiota composition of 19 PD patients who had not previously been exposed to Levodopa. Patients provided two stool samples prior to and two samples 90 days after starting Levodopa. Motor impairment (MDS-UPDRS Part III), diet, and other patient characteristics were assessed. 16S rRNA gene amplicon sequencing was used to characterize the microbiota. We examined, cross-sectionally and longitudinally, the associations between Levodopa use and alpha and beta diversity and performed feature-wise, multivariate modeling to identify taxa associated longitudinally with Levodopa use and with improvement in motor function after Levodopa administration. Results: We did not observe significant differences in alpha or beta diversity before vs. after initiation of Levodopa. In longitudinal feature-wise analyses, at the genus level, no taxa were significantly associated with Levodopa use after false discovery rate (FDR) correction (q < 0.05). We observed a marginally lower relative abundance of bacteria belonging to Clostridium group IV in PD patients who experienced a medium or large improvement in motor impairment in response to Levodopa compared to those with a small response [β = −0.64 (SE: 0.18), p-trend: 0.00015 p-FDR: 0.019]. Conclusions: In this study, Levodopa was not associated with changes in microbiota composition in this longitudinal analysis. The association between abundance of Clostridium group IV and short-term motor symptom response to Levodopa is preliminary and should be investigated in larger, longer-term studies, that include a control group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2021.574529

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 21

  1. Kalia, 2015, Parkinson's disease, Lancet., 386, 896, 10.1016/S0140-6736(14)61393-3 · DOI · Paper page
  2. Schwiertz, 2018, Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease, Parkinsonism Related Disord., 50, 104, 10.1016/j.parkreldis.2018.02.022 · DOI · Paper page
  3. Dehay, 2016, Alpha-synuclein propagation: New insights from animal models, Mov Disord., 31, 161, 10.1002/mds.26370 · DOI
  4. Unger, 2016, Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls, Parkinsonism Related Disord., 32, 66, 10.1016/j.parkreldis.2016.08.019 · DOI · Paper page
  5. Bedarf, 2017, Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients, Genome Med., 9, 39, 10.1186/s13073-017-0428-y · DOI · Paper page
  6. Pereira, 2017, Oral and nasal microbiota in Parkinson's disease, Parkinsonism Related Disord., 38, 61, 10.1016/j.parkreldis.2017.02.026 · DOI · Paper page
  7. Sampson, 2016, Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease, Cell., 167, 1469, 10.1016/j.cell.2016.11.018 · DOI · Paper page
  8. Qian, 2018, Alteration of the fecal microbiota in Chinese patients with Parkinson's disease, Brain Behav Immun., 70, 194, 10.1016/j.bbi.2018.02.016 · DOI · Paper page
  9. Barichella, 2019, Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism, Mov Disord., 34, 396, 10.1002/mds.27581 · DOI · Paper page
  10. Hughes, 1993, A clinicopathologic study of 100 cases of Parkinson's disease, Arch Neurol., 50, 140, 10.1001/archneur.1993.00540020018011 · DOI · Paper page
  11. Goetz, 2004, Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations, Mov Disord., 19, 1020, 10.1002/mds.20213 · DOI · Paper page
  12. Kozich, 2013, Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform, Appl Environ Microbiol., 79, 5112, 10.1128/AEM.01043-13 · DOI · Paper page
  13. Edgar, 2013, UPARSE: highly accurate OTU sequences from microbial amplicon reads, Nature methods., 10, 996, 10.1038/nmeth.2604 · DOI · Paper page
  14. Bolyen, 2019, Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2, Nat Biotechnol., 37, 852, 10.1038/s41587-019-0209-9 · DOI · Paper page
  15. Mortensen, 1996, Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease, Scand J Gastroenterol Suppl., 216, 132, 10.3109/00365529609094568 · DOI · Paper page
  16. Heinken, 2019, Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease, Microbiome., 7, 75, 10.1186/s40168-019-0689-3 · DOI · Paper page
  17. Umesaki, 1999, Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system, Infect Immunity., 67, 3504, 10.1128/IAI.67.7.3504-3511.1999 · DOI · Paper page
  18. Atarashi, 2011, Induction of colonic regulatory T cells by indigenous Clostridium species, Science., 331, 337, 10.1126/science.1198469 · DOI · Paper page
  19. Tansey, 2007, Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention, Exp Neurol., 208, 1, 10.1016/j.expneurol.2007.07.004 · DOI · Paper page
  20. Saunders, 2012, CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease, J Neuroimmune Pharmacol., 7, 927, 10.1007/s11481-012-9402-z · DOI · Paper page
  21. McGeer, 1988, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains, Neurology., 38, 1285, 10.1212/WNL.38.8.1285 · DOI · Paper page

Cited by

See all 30

Metadata

Authors
Palacios, N., Hannoun, A., Flahive, J., Ward, D., Goostrey, K., Deb, A., & Smith, K. M.
Venue
Frontiers in Neurology
Published
2021-03-04
Volume
12
ISSN
1664-2295
Cited by
30
References
19
Funders
National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.